108 related articles for article (PubMed ID: 9361911)
1. Triplex-forming oligonucleotides can modulate aquaporin-5 gene expression in epithelial cells.
Delporte C; Panyutin IG; Sedelnikova OA; Lillibridge CD; O'Connell BC; Baum BJ
Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):523-9. PubMed ID: 9361911
[TBL] [Abstract][Full Text] [Related]
2. Use of polyethylenimine-adenovirus complexes to examine triplex formation in intact cells.
Hoque AT; Sedelnikova OA; Luu AN; Swaim WD; Panyutin IG; Baum BJ
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):229-41. PubMed ID: 10984117
[TBL] [Abstract][Full Text] [Related]
3. Use of triplex-forming oligonucleotides and adenoviral constructs for studying the regulation of gene expression.
Shamsul Hoque AT; Panyutin IG; Baum BJ
Methods; 1999 Jul; 18(3):266-72. PubMed ID: 10454984
[TBL] [Abstract][Full Text] [Related]
4. Modifying the NH2 and COOH termini of aquaporin-5: effects on localization in polarized epithelial cells.
Wellner RB; Hong S; Cotrim AP; Swaim WD; Baum BJ
Tissue Eng; 2005; 11(9-10):1449-58. PubMed ID: 16259600
[TBL] [Abstract][Full Text] [Related]
5. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
[TBL] [Abstract][Full Text] [Related]
6. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
7. Sequence-specific gene cleavage in intact mammalian cells by 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide.
Sedelnikova OA; Karamychev VN; Panyutin IG; Neumann RD
Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):43-9. PubMed ID: 12022689
[TBL] [Abstract][Full Text] [Related]
8. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
9. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
10. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides.
Graham MK; Brown TR; Miller PS
Biochemistry; 2015 Apr; 54(13):2270-82. PubMed ID: 25768916
[TBL] [Abstract][Full Text] [Related]
11. Ligand-mediated transcription elongation control using triplex-based padlock oligonucleotides.
Bello-Roufaï M; Roulon T; Escudé C
Chem Biol; 2004 Apr; 11(4):509-16. PubMed ID: 15123245
[TBL] [Abstract][Full Text] [Related]
12. Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting.
Lacroix L; Lacoste J; Reddoch JF; Mergny JL; Levy DD; Seidman MM; Matteucci MD; Glazer PM
Biochemistry; 1999 Feb; 38(6):1893-901. PubMed ID: 10026270
[TBL] [Abstract][Full Text] [Related]
13. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
McGuffie EM; Pacheco D; Carbone GM; Catapano CV
Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
[TBL] [Abstract][Full Text] [Related]
14. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide.
Chan PP; Lin M; Faruqi AF; Powell J; Seidman MM; Glazer PM
J Biol Chem; 1999 Apr; 274(17):11541-8. PubMed ID: 10206960
[TBL] [Abstract][Full Text] [Related]
15. Triplex-forming oligonucleotides as potential tools for modulation of gene expression.
Rogers FA; Lloyd JA; Glazer PM
Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):319-26. PubMed ID: 16101484
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
Kim HG; Miller DM
Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
[TBL] [Abstract][Full Text] [Related]
18. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
19. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD
Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of monocyte chemoattractant protein-1 gene expression in human embryonal kidney cells by specific triple helix-forming oligonucleotides.
Marchand P; Resch K; Radeke HH
J Immunol; 2000 Feb; 164(4):2070-6. PubMed ID: 10657660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
